![](/img/cover-not-exists.png)
Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor)
Klotz, Luisa, Grützke, Berit, Eveslage, Maria, Deppe, Michael, Gross, Catharina C., Kirstein, Lucienne, Posevitz-Fejfar, Anita, Schneider-Hohendorf, Tilman, Schwab, Nicholas, Meuth, Sven G., Wiendl, HVolume:
15
Language:
english
Journal:
BMC Neurology
DOI:
10.1186/s12883-015-0354-9
Date:
December, 2015
File:
PDF, 465 KB
english, 2015